JH
Jiangsu Hansoh Pharmaceutical Group Co., Ltd
Manufacturer · Jiangsu, China
Overview
Jiangsu Hansoh Pharmaceutical Group was founded in 1995 and is the principal subsidiary of Hansoh Pharma (HKEX: 3692). It develops, makes and sells drugs in oncology, metabolism, immunology, CNS and anti-infectives. It holds active US Type II DMFs for the peptide APIs degarelix and icatibant.
Capabilities
- Peptide APIs
- Finished dosage forms
- Innovative drug R&D
- Oncology and metabolic products
Quality signals
| GMP evidence | Not found |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |